[
  {
    "ts": null,
    "headline": "What Elevance Health (ELV)'s Scale-Driven Efficiency Amid Membership Declines Means For Shareholders",
    "summary": "In recent weeks, analysts including RBC Capital and Wolfe Research have reiterated positive views on Elevance Health, citing its scale advantages and strong capital efficiency ahead of its late-January 2026 earnings release. At the same time, Elevance’s shrinking customer base over the past two years raises important questions about how competition and product positioning are affecting long-term demand. We’ll now examine how analyst optimism around Elevance’s scale-driven efficiency shapes...",
    "url": "https://finnhub.io/api/news?id=d7a73cc0065557e2e905c457bcfaf31c01a2579ac5b8dcc9f8a8bae9cb309188",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769281726,
      "headline": "What Elevance Health (ELV)'s Scale-Driven Efficiency Amid Membership Declines Means For Shareholders",
      "id": 138247958,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "In recent weeks, analysts including RBC Capital and Wolfe Research have reiterated positive views on Elevance Health, citing its scale advantages and strong capital efficiency ahead of its late-January 2026 earnings release. At the same time, Elevance’s shrinking customer base over the past two years raises important questions about how competition and product positioning are affecting long-term demand. We’ll now examine how analyst optimism around Elevance’s scale-driven efficiency shapes...",
      "url": "https://finnhub.io/api/news?id=d7a73cc0065557e2e905c457bcfaf31c01a2579ac5b8dcc9f8a8bae9cb309188"
    }
  },
  {
    "ts": null,
    "headline": "A Look At Elevance Health (ELV) Valuation As Q4 Earnings Approach And Cost Pressures Mount",
    "summary": "Elevance Health (ELV) is approaching its fourth quarter 2025 earnings release, with investors focused on how revenue growth compares with rising expenses from digital investments and higher benefit costs that could influence profit margins. See our latest analysis for Elevance Health. At a share price of US$371.06, Elevance Health has seen an 8.1% 1 month share price return and an 8.4% 3 month share price return. However, its 1 year total shareholder return of a 5.7% decline and 3 year total...",
    "url": "https://finnhub.io/api/news?id=9819b0370b1f5abb56d66ad455efbf94cb0510c887b9de20373f34b8bfeb3f47",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769231258,
      "headline": "A Look At Elevance Health (ELV) Valuation As Q4 Earnings Approach And Cost Pressures Mount",
      "id": 138231658,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ELV",
      "source": "Yahoo",
      "summary": "Elevance Health (ELV) is approaching its fourth quarter 2025 earnings release, with investors focused on how revenue growth compares with rising expenses from digital investments and higher benefit costs that could influence profit margins. See our latest analysis for Elevance Health. At a share price of US$371.06, Elevance Health has seen an 8.1% 1 month share price return and an 8.4% 3 month share price return. However, its 1 year total shareholder return of a 5.7% decline and 3 year total...",
      "url": "https://finnhub.io/api/news?id=9819b0370b1f5abb56d66ad455efbf94cb0510c887b9de20373f34b8bfeb3f47"
    }
  }
]